Global Atrial Fibrillation Devices Market Growth 2023-2029
Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Current treatments span a spectrum of non-invasive to highly invasive options and include medical and surgical variants. The success of the MAZE procedure and its successors has led to the development of surgical ablation devices designed to mark cardiac tissue in a manner similar to suture lines, thereby disrupting the path of the electrical impulses causing the patient’s AF.
LPI (LP Information)' newest research report, the “Atrial Fibrillation Devices Industry Forecast” looks at past sales and reviews total world Atrial Fibrillation Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Atrial Fibrillation Devices sales for 2023 through 2029. With Atrial Fibrillation Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atrial Fibrillation Devices industry.
This Insight Report provides a comprehensive analysis of the global Atrial Fibrillation Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atrial Fibrillation Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Atrial Fibrillation Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atrial Fibrillation Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atrial Fibrillation Devices.
The global Atrial Fibrillation Devices market size is projected to grow from US$ 2838.9 million in 2022 to US$ 5950.6 million in 2029; it is expected to grow at a CAGR of 5950.6 from 2023 to 2029.
The leading manufacturers of atrial fibrillation devices include Abbott, Boston Scientific, Biosense Webster, etc, with the top 2 accounting for about 60%.
North America is the largest market with about 37%, followed by Europe with about 27%.In terms of product, catheter ablation is the largest segment, with a share over 88%. And in terms of application, the largest application is ambulatory surgical centers, followed by hospitals.
This report presents a comprehensive overview, market shares, and growth opportunities of Atrial Fibrillation Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Catheter Ablation
Maze Surgery
Segmentation by application
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Boston Scientific
Biosense Webster
Medtronic
Japan Lifeline
AtriCure
Biotronik
Philips
Synaptic Medical
Osypka AG
MicroPort Scientific
CardioFocus
Lepu Medical
APT Med
TZ Medical
Johnson & Johnson
Key Questions Addressed in this Report
What is the 10-year outlook for the global Atrial Fibrillation Devices market?
What factors are driving Atrial Fibrillation Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atrial Fibrillation Devices market opportunities vary by end market size?
How does Atrial Fibrillation Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook